109 results on '"Kobayashi M"'
Search Results
2. PCR241 Measuring Preferences for Stroke Rehabilitation Using a Discrete Choice Experiment
3. EE448 The Burden of Illness for Metastatic Synovial Sarcoma (MSS) and Myxoid Round Cell Liposarcoma (MMRCLS): A Seer-Medicare Analysis
4. PNS394 DEVELOPMENT OF A MULTIPLICATIVE MULTI-ATTRIBUTE AND SINGLE-ATTRIBUTE UTILITY FUNCTION FOR THE HUI3 IN JAPAN
5. PRM71 - ESTIMATION OF THE NUMBER OF PNEUMONIA PATIENTS IN JAPAN USING PUBLIC REAL-WORLD DATA
6. PCN188 - ASSESSING THE ROBUSTNESS OF A COST-EFFECTIVENESS ANALYSIS OF LENVATINIB VERSUS SORAFENIB IN UNRESECTABLE HEPATOCELLULAR CARCINOMA IN JAPAN
7. An Economic Evaluation of Migalastat Versus ERT for the Treatment of Fabry Disease in Japan
8. Preference-Based Health-Related Quality Of Life For Heart Disease Patients In Japan
9. Cost-Minimization Analysis of Vercise DBS System for Parkinson’s Disease in Japan
10. Economic Burden of Atrial Fibrillation in Japan
11. Economic Evaluation of Egfr Control In Patients With Chronic Kidney Disease In Japan
12. Reliability And Validity Of Two Proxy Versions Of EQ-5D-5L In Japan
13. Burden Of Ulcerative Colitis In Japan
14. Cost-Effectiveness Analysis For Treatment Of Parkinson’s Disease: A Systematic Review
15. Construction of System Dynamics Model for Medical Care System of Japan
16. Comparison Between Eq-5d And Hui In Japanese Population Norms
17. Role Of Pharmacoeconomic Analysis In Pricing Decision In Japan
18. Study on Cost-Effectiveness Analysis for Treatment of Major Depression Disease: a Systematic Review of Literature From 2004-2014
19. Study On Cost-Effectiveness Analysis For Multiple Myeloma Treatment: A Systematic Review Of Literature From 2004-2014
20. Study on Cost-Effectiveness Analysis For Ulcerative Colitis Treatment: A Systematic Review of Literature From 2004-2014
21. Comparison Between The Interim Eq-5d-5l Score And The New Japanese Scoring In Stroke Patients
22. PSY18 - An Economic Evaluation of Migalastat Versus ERT for the Treatment of Fabry Disease in Japan
23. PMD23 - Cost-Minimization Analysis of Vercise DBS System for Parkinson’s Disease in Japan
24. PMD15 - Economic Burden of Atrial Fibrillation in Japan
25. PCV47 - Preference-Based Health-Related Quality Of Life For Heart Disease Patients In Japan
26. Cost-Effectiveness Analysis of Condoliase In Patients With Lumbar Disc Herniation In Japan
27. PHP179 - Reliability And Validity Of Two Proxy Versions Of EQ-5D-5L In Japan
28. PHS26 - Burden Of Ulcerative Colitis In Japan
29. PUK9 - Economic Evaluation of Egfr Control In Patients With Chronic Kidney Disease In Japan
30. PND43 - Cost-Effectiveness Analysis For Treatment Of Parkinson’s Disease: A Systematic Review
31. PIH25 - Comparison Between Eq-5d And Hui In Japanese Population Norms
32. PHP33 - Construction of System Dynamics Model for Medical Care System of Japan
33. Proposal of Economic Evaluation Guideline in Japan
34. The Survey of the Japan-Style Premium Scheme in Pharmaceutical Pricing Decisions
35. Comparing the Performance of the EQ-5D-5L with the EQ-5D-3L in Stroke Patients in Japan
36. PHS44 Economic Evaluation of Universal Hepatitis B Vaccination Strategy in Japan
37. PMH24 - Study on Cost-Effectiveness Analysis for Treatment of Major Depression Disease: a Systematic Review of Literature From 2004-2014
38. PMS49 - Cost-Effectiveness Analysis of Condoliase In Patients With Lumbar Disc Herniation In Japan
39. PUK6 EVALUATION OF PSYCHOMETRIC PROPERTIES OF THE JAPANESE VERSION OF THE NOCTURIA QUALITY OF LIFE QUASTIONNAIRE (N-QOL)
40. PMH8 HEALTH-CARE UTILIZATION COSTS AMONG SCHIZOPHRENIA PATIENTS TREATED WITH OLANZAPINE OR RISPERIDONE IN JAPAN
41. PMH59 SYSTEM DYNAMICS SIMULATION FOR ACUTE SCHIZOPHRENIA TREATMENT
42. PMS57 COST-UTILITY ANALYSIS OF BALLOON KYPHOPLASTY FOR PATIENTS WITH OSTEOPOROTIC VERTEBRAL COMPRESSION FRACTURES IN JAPAN
43. PDB31 COST-EFFECTIVENESS ANALYSIS OF VOGLIBOSE FOR PREVENTION OF TYPE-2 DIABETES MELLITUS IN JAPANESE INDIVIDUALS WITH IMPAIRED GLUCOSE TOLERANCE
44. PDB44 COST-EFFECTIVENESS OF THE USE OF ANGIOTENSIN-II-RECEPTER BLOCKERS IN PATIENTS WITH TYPE 2 DIABETES AND NEPHROPATHY IN JAPAN
45. PMH76 COST ESTIMATION OF PSYCHIATRIC CARE IN THE JAPANESE HOSPITAL USING SYSTEM DYNAMICS SIMULATION
46. PIN35 COST-EFFECTIVENESS ANALYSIS OF PALIVIZUMAB FOR RESPIRATORY SYNCYTIAL VIRUS INFECTION IN HIGH-RISK INFANTS IN JAPAN
47. PND31 THE IMPACT OF CHRONIC INSOMNIA ON PRODUCTIVITY IN THE US, FRANCE, AND JAPAN
48. PRS8 COST-EFFECTIVENESS ANALYSIS OF TIOTROPIUM FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS IN JAPAN
49. PST1 ECONOMIC EVALUATION OF SIROLIMUS-ELUTING STENTS IN JAPAN
50. PDB2 COST-EFFECTIVENESS ANALYSIS OF GLYCEMIC CONTROL WITH PIOGLITAZONE HYDROCHLORIDE FOR JAPANESE PATIENTS WITH TYPE II DIABETES
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.